Cabolong (Cabozantinib) Tablets
Salt Name: Cabozantinib. Brand Name: Cabolong Tablets. It is used to treat advanced kidney cancer, liver cancer, and thyroid cancer. Cabozantinib (Brand name Cabolong) is available in India Brand Name Cabolong Generic Name Cabozantinib Strength 20 mg Manufacturer MSN Laboratories What is the cost of Cabozantinib in India? Place your order today to receive authentic medications, enjoy maximum discounts on medicines, prescription drugs, and health products. Aark Pharmaceuticals, network in India ( New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur ), is an authorized nationwide supplier and distributor of generic API pharma products “Cabolong (Cabozantinib) Tablets ” in India, and this medication is accessible at Aark’s offices across the country.
About Cabolong (Cabozantinib) Tablets
Description Cabozantinib available in India? Cabozantinib is the salt name for the drug sold under the brand name Cabolong. It is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small-molecule tyrosine-kinase inhibitor (TKI) of c-Met (HGFR) and VEGFR2, and also inhibits AXL, RET, and FLT3. How to buy in India? Buy Cabolong (Cabozantinib) directly from Aark Pharmaceuticals at discounted pricing. The order will be confirmed only after the receipt of a valid prescription of the doctor and import permit if applicable. The product will be available across India on request. Cabozantinib is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at +91 999915 6233 , You can also make an inquiry by emailing us at sales@aarkpharma.co.in , sales@aarkpharma.com , WhatsApp: +91 9999156233 . Aark Pharmaceuticals, A Leading ISO. 9001.2008 approved C&F, distributors, stockist & retailer of anti-cancer, anti-HIV, life-saving medicines and medical and surgical devices. Our organization is customer-oriented and strongly believes in the quality and timely supply of superior medicines at an economical rate. NEWS / Updates Cabozantinib Approval for NET Treatment. FDA approves cabozantinib for adults and pediatric patients 12 years of age and older with pNET and epNET. FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer. Written By Mr. Sandeep Tomar (D. pharma) Last updated 11 July 2025 | 10:10 AM (IST)
